What this study is
This study aims to pilot "Maya," a mobile cognitive behavioral therapy app, for use in adults with stroke experiencing depression and/or anxiety. This study will assess the acceptability, feasibility, and preliminary efficacy of Maya within the acute rehabilitation period.
What's being tested
- Mobile Cognitive Behavioral Therapy App
Intervention · DEVICE
A mobile cognitive behavioral therapy (CBT) app called "Maya" that includes modules with educational content and teaching and practice of strategies that address depression and anxiety after stroke.
Study details
- Sponsor
- Weill Medical College of Cornell University
- Conditions
- Anxiety · Stroke · Depression - Major Depressive Disorder
- Enrolling
- 10 people
- Starts
- 2026-11
- Est. completion
- 2029-03
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 79 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age 18-79
- Positive screen on the Hospital Anxiety and Depression Scale (HADS), either the HADSD (depression, score >= 8) and/or HADS-A (anxiety, score >= 8).
- Stroke that occurred within 1 month prior to study initiation.
- Capacity to provide consent as determined by the UCSD Brief Assessment for Capacity to Consent (UBACC)
- Montreal Cognitive Assessment (MoCA) score greater than or equal to 18, indicating no more than mild cognitive difficulties
- Ability to use iPhone or iPad independently or through the assistance of a caregiver (participants will use their own iPhone if they have one, otherwise they will be loaned an iPad by the study team)
- Able to adhere to all study requirements and willingness to participate in the full study duration
You can't join if
- Aphasia or neglect that would interfere with use of the app, as determined through evaluation by speech-language pathology and occupational therapy conducted as part of standard clinical care
- Non-fluency in English
- History of a major neurologic disorder or of serious mental illness (bipolar or psychotic disorder, alcohol or substance use disorder as assessed through chart review)
- Active suicidal ideation requiring a higher level of care
- Severe depression and/or anxiety based on the initial evaluation and clinical judgment of the PI, which warrants a higher level of care and/or immediate referral to psychiatric services
- Any other clinical or medical reason in the initial evaluation that suggests the study is not appropriate for the participant
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openWeill Cornell Medicine
New York, New York, United States
- Abhishek Jaywant, PhD · Contact212-746-4666abj2006@med.cornell.edu
Recruiting
Study team
Sponsor
Weill Medical College of Cornell University
Study ID 26-01029701
Principal investigator
Abhishek Jaywant, PhD
Weill Medical College of Cornell University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.